The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides

BMC Medical Genetics

Volumn 9, Issue , 2008, Pages

  Dallongeville, Jean ^a   Cottel, Dominique ^a   Wagner, Aline ^b   Ducimetière, Pierre ^a   Ruidavets, Jean Bernard ^a   Arveiler, Dominique ^b   Bingham, Annie ^a   Ferrières, Jean ^a   Amouyel, Philippe ^a   Meirhaeghe, Aline ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; CYTOSINE; GLUCOSE; GUANINE; HIGH DENSITY LIPOPROTEIN; SERINE; THREONINE; THYMINE; TRIACYLGLYCEROL; TRYPTOPHAN; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A;

ADULT; ARTICLE; BLOOD PRESSURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FRANCE; GENE CLUSTER; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ALLELE; BLOOD; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; APOLIPOPROTEINS A; DIABETES MELLITUS, TYPE 2; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 52449087039     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-9-84     Document Type: Article

References (34)

1. Reaven GM Banting lecture 1988. Role of insulin resistance in human disease Diabetes 1988, 37: 1595-1607. 10.2337/diabetes.37.12.1595 3056758
2. Timar O Sestier F Levy E Metabolic syndrome X: A review Can J Cardiol 2000, 16:779-789. 10863169
3. Mitchell BD Kammerer CM Mahaney MC Blangero J Comuzzie AG Atwood LD Haffner SM Stern MP MacCluer JW Genetic analysis of the IRS. Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures Arterioscler Thromb Vasc Biol 1996, 16:281-288. 8620344
4. Hong Y Pedersen NL Brismar K de Faire U Genetic and environmental architecture of the features of the insulin-resistance syndrome Am J Hum Genet 1997, 60:143-152. 1712553 8981957
5. Chen W Srinivasan SR Elkasabany A Berenson GS The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: The Bogalusa Heart Study Atherosclerosis 1999, 145:197-205. 10.1016/ S0021-9150(99)00025-8 10428311
6. Dallongeville J Helbecque N Cottel D Amouyel P Meirhaeghe A The Gly16→Arg16 and Gln27→Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men J Clin Endocrinol Metab 2003, 88:4862-4866. 10.1210/jc.2003-030173 14557466
7. Meirhaeghe A Cottel D Amouyel P Dallongeville J Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women Diabetes 2005, 54:3043-3048. 10.2337/diabetes.54.10.3043 16186413
8. Yamada Y Kato K Hibino T Yokoi K Matsuo H Segawa T Watanabe S Ichihara S Yoshida H Satoh K Nozawa Y Prediction of genetic risk for metabolic syndrome Atherosclerosis 2007, 191:298-304. 10.1016/ j.atherosclerosis.2006.05.035 16806226
9. Yamada Y Ichihara S Kato K Yoshida T Yokoi K Matsuo H Watanabe S Metoki N Yoshida H Satoh K Aoyagi Y Yasunaga A Park H Tanaka M Lee W Nozawa Y Genetic risk for metabolic syndrome: Examination of candidate gene polymorphisms related to lipid metabolism in Japanese people J Med Genet 2008, 45:22-28. 10.1136/jmg.2007.052415 17766366
10. Grallert H Sedlmeier EM Huth C Kolz M Heid IM Meisinger C Herder C Strassburger K Gehringer A Haak M Giani G Kronenberg F Wichmann HE Adamski J Paulweber B Illig T Rathmann W APOA5 variants and metabolic syndrome in Caucasians J Lipid Res 2007, 48:2614-2621. 10.1194/ jlr.M700011-JLR200 17768309
11. Kisfali P Mohas M Maasz A Hadarits F Marko L Horvatovich K Oroszlan T Bagosi Z Bujtor Z Gasztonyi B Wittmann I Melegh B Apolipoprotein A5 IVS3+ 476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians Circ J 2008, 72:40-43. 10.1253/circj.72.40 18159097
12. Maasz A Kisfali P Horvatovich K Mohas M Marko L Csongei V Farago B Jaromi L Magyari L Safrany E Sipeky C Wittmann I Melegh B Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome Pathol Oncol Res 2007, 13:243-247. 17922054
13. Pennacchio LA Olivier M Hubacek JA Cohen JC Cox DR Fruchart JC Krauss RM Rubin EM An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing Science 2001, 294:169-173. 10.1126/ science.1064852 11588264
14. Baroukh N Bauge E Akiyama J Chang J Afzal V Fruchart JC Rubin EM Fruchart-Najib J Pennacchio LA Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice Arterioscler Thromb Vasc Biol 2004, 24:1297-1302. 10.1161/ 01.ATV.0000130463.68272.1d 15117734
15. Fruchart-Najib J Bauge E Niculescu LS Pham T Thomas B Rommens C Majd Z Brewer B Pennacchio LA Fruchart JC Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5 Biochem Biophys Res Commun 2004, 319:397-404. 10.1016/j.bbrc.2004.05.003 15178420
16. Schaap FG Rensen PC Voshol PJ Vrins C Vliet van der HN Chamuleau RA Havekes LM Groen AK van Dijk KW ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis J Biol Chem 2004, 279:27941-27947. 10.1074/jbc.M403240200 15090553
17. van Dijk KW Rensen PC Voshol PJ Havekes LM The role and mode of action of apolipoproteins CIII and AV: Synergistic actors in triglyceride metabolism? Curr Opin Lipidol 2004, 15:239-246. 10.1097/ 00041433-200406000-00002 15166778
18. Merkel M Loeffler B Kluger M Fabig N Geppert G Pennacchio LA Laatsch A Heeren J Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase J Biol Chem 2005, 280:21553-21560. 10.1074/ jbc.M411412200 15774484
19. Nowak M Helleboid-Chapman A Jakel H Martin G Duran-Sandoval D Staels B Rubin EM Pennacchio LA Taskinen MR Fruchart-Najib J Fruchart JC Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: Role of upstream stimulatory factor Mol Cell Biol 2005, 25:1537-1548. 548024 15684402 10.1128/MCB.25.4.1537-1548.2005
20. Pennacchio LA Olivier M Hubacek JA Krauss RM Rubin EM Cohen JC Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels Hum Mol Genet 2002, 11:3031-3038. 10.1093/hmg/ 11.24.3031 12417524
21. Hubacek JA Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants Clin Chem Lab Med 2005, 43:897-902. 10.1515/ CCLM.2005.153 16176166
22. Chandak GR Ward KJ Yajnik CS Pandit AN Bavdekar A Joglekar CV Fall CH Mohankrishna P Wilkin TJ Metcalf BS Weedon MN Frayling TM Hattersley AT Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans BMC Med Genet 2006, 7:76. 1618828 17032446 10.1186/1471-2350-7-76
23. Lai CQ Parnell LD Ordovas JM The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk Curr Opin Lipidol 2005, 16:153-166. 10.1097/01.mol.0000162320.54795.68 15767855
24. Talmud PJ Hawe E Martin S Olivier M Miller GJ Rubin EM Pennacchio LA Humphries SE Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides Hum Mol Genet 2002, 11:3039-3046. 10.1093/hmg/11.24.3039 12417525
25. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): A major international collaboration. WHO MONICA Project Principal Investigators J Clin Epidemiol 1988, 41:105-114. 10.1016/0895-4356(88)90084-4 3335877
26. Grundy SM Cleeman JI Daniels SR Donato KA Eckel RH Franklin BA Gordon DJ Krauss RM Savage PJ Smith SC Jr Spertus JA Costa F Diagnosis and management of the metabolic syndrome. An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Executive summary Cardiol Rev 2005, 13:322-327. 16708441
27. Alberti KG Zimmet P Shaw J The metabolic syndrome - a new worldwide definition Lancet 2005, 366:1059-1062. 10.1016/S0140-6736(05)67402-8 16182882
28. Miltiadous G Hatzivassiliou M Bashiardes E Bairaktari E Cariolou MA Elisaf M Genetic polymorphisms of the apolipoprotein A-IV in a Greek population and their relation to plasma lipid and lipoprotein levels Clin Genet 2002, 62: 208-213. 10.1034/j.1399-0004.2002.620304.x 12220435
29. Slatkin M Excoffier L Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm Heredity 1996, 76:377-383. 10.1038/hdy.1996.55 8626222
30. Lewontin RC The interaction of selection and linkage. I. General considerations; heterotic models Genetics 1964, 49:49-67. 1210557 17248194
31. Tregouet DA Barbaux S Escolano S Tahri N Golmard JL Tiret L Cambien F Specific haplotypes of the P-selectin gene are associated with myocardial infarction Hum Mol Genet 2002, 11:2015-2023. 10.1093/hmg/ 11.17.2015 12165563
32. Tregouet DA Escolano S Tiret L Mallet A Golmard JL A new algorithm for haplotype-based association analysis: The Stochastic-EM algorithm Ann Hum Genet 2004, 68:165-177. 10.1046/j.1529-8817.2003.00085.x 15008795
33. de Koning L Merchant AT Pogue J Anand SS Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies Eur Heart J 2007, 28:850-856. 10.1093/eurheartj/ehm026 17403720
34. Kusterer K Pohl T Fortmeyer HP Marz W Scharnagl H Oldenburg A Angermuller S Fleming I Usadel KH Busse R Chronic selective hypertriglyceridemia impairs endothelium-dependent vasodilatation in rats Cardiovasc Res 1999, 42:783-793. 10.1016/S0008-6363(98)00331-9 10533619